Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Return on Invested Capital (2020 - 2023)

Historic Return on Invested Capital for Terns Pharmaceuticals (TERN) over the last 4 years, with Q3 2023 value amounting to 0.32%.

  • Terns Pharmaceuticals' Return on Invested Capital rose 500.0% to 0.32% in Q3 2023 from the same period last year, while for Sep 2023 it was 0.32%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.29% for FY2022, which is 15200.0% up from last year.
  • Latest data reveals that Terns Pharmaceuticals reported Return on Invested Capital of 0.32% as of Q3 2023, which was up 500.0% from 0.26% recorded in Q2 2023.
  • Terns Pharmaceuticals' 5-year Return on Invested Capital high stood at 0.34% for Q4 2020, and its period low was 0.98% during Q1 2021.
  • Its 4-year average for Return on Invested Capital is 0.3%, with a median of 0.29% in 2021.
  • Per our database at Business Quant, Terns Pharmaceuticals' Return on Invested Capital tumbled by -6400bps in 2021 and then surged by 6500bps in 2022.
  • Quarter analysis of 4 years shows Terns Pharmaceuticals' Return on Invested Capital stood at 0.34% in 2020, then tumbled by -190bps to 0.3% in 2021, then rose by 11bps to 0.27% in 2022, then decreased by -20bps to 0.32% in 2023.
  • Its last three reported values are 0.32% in Q3 2023, 0.26% for Q2 2023, and 0.25% during Q1 2023.